These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 27008492)
1. The potential influence of atherogenic dyslipidemia on the severity of chronic Chagas heart disease. Peverengo L; Rodeles L; Vicco MH; Marcipar I Rev Assoc Med Bras (1992); 2016; 62(1):45-7. PubMed ID: 27008492 [TBL] [Abstract][Full Text] [Related]
2. Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease. Vicco MH; Ferini F; Rodeles L; Cardona P; Bontempi I; Lioi S; Beloscar J; Nara T; Marcipar I; Bottasso OA Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):791-6. PubMed ID: 24773859 [TBL] [Abstract][Full Text] [Related]
3. Combined analysis of cross-reacting antibodies anti-β1AR and anti-B13 in advanced stages of Chagas heart disease. Rodeles LM; Vicco MH; Bontempi IA; Siano A; Tonarelli G; Bottasso OA; Arias P; Marcipar IS Trop Med Int Health; 2016 Dec; 21(12):1545-1551. PubMed ID: 27699992 [TBL] [Abstract][Full Text] [Related]
4. β1-selective adrenoceptor antagonists increase plasma levels of anti-p2β antibodies and decrease cardiac involvement in chronic progressive Chagas heart disease. Vicco MH; Pujato N; Bontempi I; Rodeles L; Marcipar I; Bottasso OA Can J Cardiol; 2014 Mar; 30(3):332-7. PubMed ID: 24370375 [TBL] [Abstract][Full Text] [Related]
5. Determination of the Th1, Th2, Th17, and Treg cytokine profile in patients with chronic Chagas heart disease and systemic arterial hypertension. Bestetti RB; Dellalibera-Joviliano R; Lopes GS; Faria-Jr M; Furlan-Daniel R; Lopes KC; Batista DR Heart Vessels; 2019 Jan; 34(1):123-133. PubMed ID: 30047012 [TBL] [Abstract][Full Text] [Related]
6. Decreased level of antibodies and cardiac involvement in patients with chronic Chagas heart disease vaccinated with BCG. Vicco MH; Bontempi IA; Rodeles L; Yodice A; Marcipar IS; Bottasso O Med Microbiol Immunol; 2014 Apr; 203(2):133-9. PubMed ID: 24374613 [TBL] [Abstract][Full Text] [Related]
7. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease. Nunes DF; Guedes PM; Andrade Cde M; Câmara AC; Chiari E; Galvão LM Trop Med Int Health; 2013 Oct; 18(10):1180-92. PubMed ID: 23906320 [TBL] [Abstract][Full Text] [Related]
8. Genetic Susceptibility to Cardiac and Digestive Clinical Forms of Chronic Chagas Disease: Involvement of the CCR5 59029 A/G Polymorphism. de Oliveira AP; Bernardo CR; Camargo AV; Ronchi LS; Borim AA; de Mattos CC; de Campos Júnior E; Castiglioni L; Netinho JG; Cavasini CE; Bestetti RB; de Mattos LC PLoS One; 2015; 10(11):e0141847. PubMed ID: 26599761 [TBL] [Abstract][Full Text] [Related]
9. Carlos Chagas Discoveries as a Drop Back to Scientific Construction of Chronic Chagas Heart Disease. Bestetti RB; Restini CB; Couto LB Arq Bras Cardiol; 2016 Jul; 107(1):63-70. PubMed ID: 27223644 [TBL] [Abstract][Full Text] [Related]
10. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes. Akanji AO; Suresh CG; Al-Radwan R; Fatania HR Metab Syndr Relat Disord; 2009 Dec; 7(6):563-9. PubMed ID: 19642911 [TBL] [Abstract][Full Text] [Related]
11. Association between atherogenic dyslipidemia and recurrent stroke risk in patients with different subtypes of ischemic stroke. Zhao L; Wang R; Song B; Tan S; Gao Y; Fang H; Lu J; Xu Y Int J Stroke; 2015 Jul; 10(5):752-8. PubMed ID: 25924059 [TBL] [Abstract][Full Text] [Related]
12. Norepinephrine and heart rate variability: a marker of dysautonomia in chronic Chagas cardiopathy. Cunha AB; Cunha DM; Pedrosa RC; Flammini F; Silva AJ; Saad EA; Kopiler DA Rev Port Cardiol; 2003 Jan; 22(1):29-52. PubMed ID: 12712809 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical course of patients with chronic heart failure secondary to chronic Chagas heart disease associated with obstructive coronary artery disease. Otaviano AP; Cardinalli-Neto A; Nakazone MA; Nogueira PR; Bestetti RB Trans R Soc Trop Med Hyg; 2023 Apr; 117(4):279-284. PubMed ID: 36349617 [TBL] [Abstract][Full Text] [Related]
15. Respiratory muscle strength, the six-minute walk test and quality of life in Chagas cardiomyopathy. Vieira FC; de Melo Marinho PÉ; Brandão DC; Barbosae e Silva O Physiother Res Int; 2014 Mar; 19(1):8-15. PubMed ID: 23703777 [TBL] [Abstract][Full Text] [Related]
16. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy. Nunes Mdo C; Rocha MO; Ribeiro AL; Colosimo EA; Rezende RA; Carmo GA; Barbosa MM Int J Cardiol; 2008 Jul; 127(3):372-9. PubMed ID: 17689706 [TBL] [Abstract][Full Text] [Related]
17. Kinins and nitric oxide in patients with chronic chagas disease and systemic arterial hypertension. Dellalibera-Joviliano R; Bestetti RB; Lopes GS; Furlan-Daniel R; Lopes KC; Faria-Junior M; Junior NI Cardiovasc Pathol; 2020; 49():107257. PubMed ID: 32674046 [TBL] [Abstract][Full Text] [Related]
18. Chagas disease, a risk factor for high blood pressure. Vicco MH; Rodeles L; Yódice A; Marcipar I Blood Press; 2014 Dec; 23(6):345-8. PubMed ID: 24738834 [TBL] [Abstract][Full Text] [Related]